Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?

MeSH terms

• Acute Kidney Injury* / chemically induced
• Acute Kidney Injury* / diagnosis
• Hepatorenal Syndrome* / drug therapy
• Humans
• Lypressin / adverse effects
• Lypressin / analogs & derivatives
• Lypressin / therapeutic use
• Terlipressin* / therapeutic use
• Vasoconstrictor Agents* / adverse effects
• Vasoconstrictor Agents* / therapeutic use